Pharmacokinetics of iron isomaltoside 1000 in patients with inflammatory bowel disease

Abstract

At the administered doses, iron isomaltoside 1000 showed first-order PK, and did not raise safety concerns in patients with IBD. The PK parameters for IBI were close to those of TI.